Policy

The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More

In late January, the American Society of Human Genetics (ASHG) released a report on its Facing our History – Building an Equitable Future initiative. Accompanying the report, the ASHG Board of Directors issued a statement that apologized for “the participation of some of its early leaders in the American eugenics movement, as well as the... Read More

ASHG recently responded to a select number of questions in a Request for Information (RFI) from the White House Office of Science and Technology Policy (OSTP) on the National Biotechnology and Biomanufacturing Initiative. OSTP released this RFI to seek public input on how advances in biotechnology and biomanufacturing can help support a strong bioeconomy. The insights... Read More

November 8 saw a midterm election during which all members of the House of Representatives and one-third of the Senate were up for re-election. Democrats retained control of the Senate and Republicans ultimately won only a narrow majority in the House. This will usher in at least two years of divided government, and experts anticipate... Read More

The 10th anniversary of the Rally for Medical Research took place on September 14, 2022. ASHG is proud to have again sponsored this event on Capitol Hill, which brought together 250 participants from more than 30 states and Washington, D.C. to meet with 190 congressional offices. Science advocates were enthusiastic to return to the capital... Read More